Host-parasite interaction in fungal infections.
The outcome of host-parasite interactions in fungal infections is determined by the balance between pathogenicity of the organism and the adequacy of the host defenses. A wide variety of host defense mechanisms are involved in protection against fungal infections. These include nonspecific mechanisms such as intact skin and mucus membranes, indigenous microbial flora, and the fungicidal activity of neutrophils and monocytes. Such mechanisms constitute the major host defense against opportunistic fungal infections caused by ubiquitous organisms of low virulence. The effective role of immunoglobulins and complement as opsonins varies with the fungal pathogen involved. Specific immune responses of both the humoral and cell-mediated type develop in response to infections by pathogenic fungi. Antibodies, in general, are not of major importance in protection against these infections. Specifically sensitized T lymphocytes produce lymphokines that activate macrophages. Activated macrophages are the major line of defense against systemic fungal pathogens. The type and degree of impairment in immune responses determines the susceptibility and severity of diseases. The type of immune response also determines the tissue reactions in these diseases and sometimes may be involved in the pathogenesis of the disease process. The role of natural killer cell activity, antibody-dependent cellular cytotoxicity, and biological response modifiers in various fungal infections has been described recently. The microbial factors of importance in fungal infections are adherence, invasion, presence of an antiphagocytic capsule, and ability to grow under altered physiological states of the host. The differences in the virulence of fungal strains is of minor importance in determining the outcome in general. The seriousness of the alteration of the host state rather than the pathogenic properties of the fungus determine the severity of the disease.
Khardori
N
N
Department of Medical Specialities, University of Texas M.D. Anderson Cancer Center, Houston 77030.
D000818:Animals; D000908:Antibodies, Fungal / Q000276:immunology; D005260:Female; D005658:Fungi / Q000276:immunology / Q000472:pathogenicity; D006801:Humans; D007108:Immune Tolerance; D007111:Immunity, Cellular; D008297:Male; D009181:Mycoses / Q000276:immunology* / Q000382:microbiology; D009894:Opportunistic Infections / Q000276:immunology* / Q000382:microbiology; D014774:Virulence
D000908:Antibodies, Fungal